動物用輸液ソリューションの市場規模、シェア、動向分析レポート：製品別、動物種別、適応症別、最終用途別、地域別、セグメント予測、2025年～2030年

動物用輸液ソリューション市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の動物用輸液ソリューション市場規模は2030年までに20億7,000万米ドルに達し、2025年から2030年までのCAGRは6.21％で拡大すると推定されています。

この成長の原動力は、動物福祉に対する意識の高まり、動物医療の進歩、ペット飼育の増加、炭疽、膵炎、口蹄疫などの病気の増加です。動物医療の進歩により、動物が受けられる治療の選択肢は広がっています。動物病院や診療所には、輸液システムなどの高度な診断・治療設備が整っており、これが市場の成長に寄与しています。

動物用として特別に設計された高度な輸液システムの開発により、投与プロセスがより効率的で正確かつ安全になりました。特殊な輸液ポンプや輸液モニタリングシステムなどのこうした技術的進歩は、患者ケアを強化し合併症のリスクを低減することで、動物用輸液ソリューション産業にプラスの影響を与えています。多くの地域で可処分所得水準が上昇しているため、ペットのヘルスケアへの支出が増加しています。ペットの飼い主は、輸液療法を含む質の高い獣医療への投資をより厭わなくなり、市場の成長に寄与しています。

COVID-19後の動物用輸液業界への影響は、世界情勢が進化を続けているため、まだ解明されていないです。COVID-19パンデミックの回復により、手術、治療、重篤な状況下で動物に提供される標準治療の一環として、動物用静注液の需要が増加しています。パンデミックの経済的影響は、ペットの飼い主や動物病院を含む多くの個人や企業に影響を与えました。経済的制約がペットの飼い主の意思決定プロセスに影響を与えた可能性があり、輸液の使用を含む、必要でない獣医学的処置や治療の減少につながった可能性があります。

さらに、北米では獣医学教育プログラムで輸液療法の重要性とさまざまな臨床状況での適切な使用が強調されているなど、さまざまな要因により、北米における動物用輸液の採用率は比較的高くなっています。獣医師および獣医療技術者は、輸液の投与、モニタリング、および管理について広範なトレーニングを受けており、輸液の適切な使用を実践しています。さらに、北米の獣医専門家は、動物に質の高いケアを提供しようと努力しています。輸液療法は、包括的な獣医学的治療の重要な要素であり、その採用は、患者ケアを最適化し、動物の回復と健康をサポートするというコミットメントによって推進されています。

動物用輸液市場レポートハイライト

• 製品別では、等張晶析液セグメントが2024年に42.00%以上のシェアで市場を独占。動物の水分補給と電解質バランスを回復・維持するため、動物医療における輸液療法では等張晶質液が頻繁に使用されます。
• 動物の種類に基づくと、コンパニオンアニマルセグメンテーションが2024年の市場を独占しました。多くの家庭ではコンパニオンアニマルをペットとして定期的に飼育しており、特に犬や猫が多いです。ペットの飼育は、動物用輸液の大きな需要につながります。これらの動物は、さまざまな健康問題、手術、重篤な治療のために輸液療法を必要とすることが多いからです。
• 適応症別では、糖尿病性ケトアシドーシス部門が2024年に28.0％以上の売上高シェアで動物用静注液市場を独占しました。
• 最終用途別では、ペットを動物病院に連れて行く人が増えていることから、動物病院セグメントが2024年の市場で最も高いシェアを占めました。静脈内水分補給療法は、患者ケアの重要な一部として動物病院で頻繁に使用されています。
• 北米は、2024年の市場で38.09%以上の最高収益シェアを占めています。北米ではペットの飼育率が高く、多くの家庭で犬、猫、小型哺乳類などのコンパニオンアニマルが飼育されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 動物用輸液ソリューション市場の変動動向と展望

• 市場系統の見通し
  • 親市場
  • 補助市場
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 動物用輸液ソリューション市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • 規制の枠組み
  • 価格分析
  • 製造、需要、サプライチェーン分析
  • 主要国別、主要種別の動物推定個体数（2024年）

第4章 動物用輸液ソリューション市場：動物種別推定・動向分析

• セグメントダッシュボード
• 動物用輸液ソリューション市場：動物種別変動分析
• 動物用輸液ソリューション市場規模と動向分析（動物種別、2018～2030年）
  • 生産動物
  • コンパニオンアニマル

第5章 動物用輸液ソリューション市場：製品別推定・動向分析

• セグメントダッシュボード
• 動物用輸液ソリューション市場：製品別変動分析
• 動物用輸液ソリューション市場規模と動向分析（製品別、2018～2030年）
  • 等張晶質液
  • 合成コロイド
  • 血液製剤
  • ブドウ糖溶液
  • 経腸栄養

第6章 動物用輸液ソリューション市場：適応症別推定・動向分析

• セグメントダッシュボード
• 動物用輸液ソリューション市場：適応症別変動分析
• 動物用輸液ソリューション市場規模と動向分析（適応症別、2018～2030年）
  • 糖尿病性ケトアシドーシス
  • 膵炎
  • 炭疽菌
  • 慢性腎臓病
  • その他

第7章 動物用輸液ソリューション市場：最終用途別推定・動向分析

• セグメントダッシュボード
• 動物用輸液ソリューション市場：最終用途別変動分析
• 動物用輸液ソリューション市場規模と動向分析（最終用途別、2018～2030年）
  • 動物病院
  • 調査機関
  • その他

第8章 動物用輸液ソリューション市場：地域別推定・動向分析

• 地域別ダッシュボード
• 動物用輸液ソリューション市場シェア、地域別、2024年および2030年
• 地域展望
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 市場参入企業の分類
• 企業の市況分析/ヒープマップ分析
• 企業プロファイル
  • Merck &Co., Inc
  • Dechra.
  • Animalcare Limited
  • Elanco Animal Health Incorporated
  • Zoetis
  • Scopio B. Braun Vet Care（B Braun SE）
• 戦略マッピング
  • 合併と買収
  • パートナーシップとコラボレーション
  • 製品発売
  • その他
• その他の主要人物一覧

List of Tables

• Table 1 List of secondary sources
• Table 2 Veterinary Intravenous (IV) Solutions Market, by region, 2018 - 2030 (USD Million)
• Table 3 Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 4 Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 5 Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 6 Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 7 North America Veterinary Intravenous (IV) Solutions Market, by country, 2018 - 2030 (USD Million)
• Table 8 North America Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 9 North America Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 10 North America Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 11 North America Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 12 U.S. Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 13 U.S. Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 14 U.S. Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 15 U.S. Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 16 Canada Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 17 Canada Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 18 Canada Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 19 Canada Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 20 Mexico Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 21 Mexico Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 22 Mexico Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 23 Mexico Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 24 Europe Veterinary Intravenous (IV) Solutions Market, by country, 2018 - 2030 (USD Million)
• Table 25 Europe Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 26 Europe Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 27 Europe Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 28 Europe Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 29 Germany Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 30 Germany Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 31 Germany Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 32 Germany Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 33 UK Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 34 UK Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 35 UK Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 36 UK Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 37 France Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 38 France Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 39 France Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 40 France Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 41 Italy Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 42 Italy Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 43 Italy Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 44 Italy Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 45 Spain Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 46 Spain Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 47 Spain Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 48 Spain Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 49 Denmark Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 50 Denmark Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 51 Denmark Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 52 Denmark Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 53 Sweden Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 54 Sweden Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 55 Sweden Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 56 Sweden Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 57 Norway Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 58 Norway Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 59 Norway Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 60 Norway Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by country, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 66 China Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 67 China Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 68 China Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 69 China Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 70 Japan Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 71 Japan Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 72 Japan Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 73 Japan Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 74 India Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 75 India Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 76 India Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 77 India Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 78 South Korea Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 79 South Korea Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 80 South Korea Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 81 South Korea Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 82 Australia Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 83 Australia Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 84 Australia Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 85 Australia Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 86 Thailand Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 87 Thailand Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 88 Thailand Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 89 Thailand Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 90 Latin America Veterinary Intravenous (IV) Solutions Market, by country, 2018 - 2030 (USD Million)
• Table 91 Latin America Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 92 Latin America Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 93 Latin America Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 94 Latin America Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 95 Brazil Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 96 Brazil Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 97 Brazil Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 98 Brazil Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 99 Argentina Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 100 Argentina Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 101 Argentina Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 102 Argentina Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 103 MEA Veterinary Intravenous (IV) Solutions Market, by country, 2018 - 2030 (USD Million)
• Table 104 MEA Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 105 MEA Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 106 MEA Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 107 MEA Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 108 South Africa Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 109 South Africa Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 110 South Africa Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 111 South Africa Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 116 UAE Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 117 UAE Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 118 UAE Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 119 UAE Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 120 Kuwait Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
• Table 121 Kuwait Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
• Table 122 Kuwait Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
• Table 123 Kuwait Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
• Table 124 Company Overview
• Table 125 Product Benchmarking
• Table 126 Financial Performance
• Table 127 Strategic Initiatives

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Veterinary Intravenous (IV) Solutions Market revenue, 2018 - 2030 (USD Million)
• Fig. 10 Veterinary Intravenous (IV) Solutions Market snapshot
• Fig. 11 Veterinary Intravenous (IV) Solutions Market driver impact
• Fig. 12 Veterinary Intravenous (IV) Solutions Market restraint impact
• Fig. 13 Veterinary Intravenous (IV) Solutions animal type key takeaways (USD Million)
• Fig. 14 Veterinary Intravenous (IV) Solutions Market: animal Type movement analysis
• Fig. 15 Companion animals market, 2018 - 2030 (USD Million)
• Fig. 16 Production animals market, 2018 - 2030 (USD Million)
• Fig. 17 Veterinary Intravenous (IV) Solutions Market Product key takeaways (USD Million)
• Fig. 18 Veterinary Intravenous (IV) Solutions Market: product movement analysis
• Fig. 19 Isotonic crystalloids market, 2018 - 2030 (USD Million)
• Fig. 20 Synthetic colloids market, 2018 - 2030 (USD Million)
• Fig. 21 Blood products market, 2018 - 2030 (USD Million)
• Fig. 22 Dextrose Solution market, 2018 - 2030 (USD Million)
• Fig. 23 Parenteral nutrition market, 2018 - 2030 (USD Million)
• Fig. 24 Veterinary Intravenous (IV) Solutions Market Indication key takeaways (USD Million)
• Fig. 25 Veterinary Intravenous (IV) Solutions Market: Indication movement analysis
• Fig. 26 Diabetic Ketoacidosis market, 2018 - 2030 (USD Million)
• Fig. 27 Pancreatitis market, 2018 - 2030 (USD Million)
• Fig. 28 Anthrax market, 2018 - 2030 (USD Million)
• Fig. 29 Chronic Kidney Disease market, 2018 - 2030 (USD Million)
• Fig. 30 Others market, 2018 - 2030 (USD Million)
• Fig. 31 Veterinary Intravenous (IV) Solutions Market by End Use key takeaways (USD Million)
• Fig. 32 Veterinary Intravenous (IV) Solutions Market: by End Use movement analysis
• Fig. 33 Veterinary Research Institutes market, 2018 - 2030 (USD Million)
• Fig. 34 Veterinary Hospitals market, 2018 - 2030 (USD Million)
• Fig. 35 Research Institutes market, 2018 - 2030 (USD Million)
• Fig. 36 Others market, 2018 - 2030 (USD Million)
• Fig. 37 Regional market place: Key takeaways
• Fig. 38 Regional outlook, 2024 & 2030
• Fig. 39 North America Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 40 U.S. Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 41 Canada Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 42 Mexico Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 43 Europe Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 44 UK Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 45 Germany Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 46 France Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 47 Italy Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 48 Spain Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 49 Denmark Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 50 Sweden Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 51 Norway Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 52 Asia Pacific Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 53 Japan Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 54 China Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 55 India Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 56 Australia Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 57 South Korea Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 58 Thailand Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 59 Latin America Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 60 Brazil Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 61 Argentina Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 62 MEA Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 63 South Africa Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 64 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 65 UAE Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 66 Kuwait Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
• Fig. 67 Market participant categorization

Veterinary Intravenous Solutions Market Growth & Trends:

The global veterinary intravenous solutions market size is estimated to reach USD 2.07 billion by 2030, expanding at a CAGR of 6.21% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is driven by increasing awareness of animal welfare, advancements in veterinary healthcare, increasing pet ownership, and the increasing prevalence of illnesses such as anthrax, pancreatitis, and mouth disease. The advancements in veterinary medicine have expanded the range of treatment options available for animals. Veterinary clinics and hospitals are equipped with advanced diagnostic and treatment facilities, including intravenous fluid administration systems, which contribute to the growth of the market.

The development of advanced IV fluid delivery systems designed specifically for veterinary use has made the administration process more efficient, accurate, and safe. These technological advancements, such as specialized infusion pumps and fluid monitoring systems, have positively impacted the veterinary intravenous solutions industry by enhancing patient care and reducing the risk of complications. Rising disposable income levels in many regions have led to increased spending on pet healthcare. Pet owners are more willing to invest in high-quality veterinary care, including intravenous fluid therapy, which contributes to the growth of the market.

The post-COVID-19 impact on the veterinary intravenous solutions industry is still unfolding as the global situation continues to evolve. The COVID-19 pandemic recovery has led to an increased demand for veterinary intravenous solutions as part of the standard care provided to animals during surgeries, treatments, and critical care situations. The economic impact of the pandemic affected many individuals and businesses, including pet owners and veterinary clinics. Financial constraints may have influenced the decision-making process for pet owners, potentially leading to a decrease in non-essential veterinary procedures and treatments, including the use of IV fluids.

Moreover, the adoption of veterinary intravenous (IV) fluid solutions in North America is relatively high due to various factors such as veterinary education programs in North America emphasizing the importance of IV fluid therapy and its appropriate use in different clinical situations. Veterinarians and veterinary technicians receive extensive training in the administration, monitoring, and management of IV fluids, ensuring their competent use in practice. Furthermore, veterinary professionals in North America strive to provide high-quality care for animals. IV fluid therapy is a crucial component of comprehensive veterinary treatment, and its adoption is driven by the commitment to optimize patient care and support the recovery and well-being of animals.

Veterinary Intravenous Solutions Market Report Highlights:

• Based on product, the isotonic crystalloids segment dominated the market with a share of over 42.00% in 2024. To restore and maintain hydration and electrolyte balance in animals, fluid therapy in veterinary medicine frequently uses isotonic crystalloid solutions
• Based on animal type, the companion animals segment dominated the market in 2024. Many homes regularly keep companion animals as pets, especially dogs and cats. Pet ownership leads to a large demand for veterinary intravenous solutions, as these animals frequently require intravenous therapy for a variety of health issues, surgeries, or critical care situations
• Based on indication, the diabetic ketoacidosis segment dominated the market for veterinary intravenous (IV) solutions with a revenue share of over 28.0% in 2024.
• Based on end-use, the veterinary hospital segment accounted for the highest share in the market 2024, as more people are taking their pets to veterinarian facilities for care. IV hydration therapy is frequently used in veterinary hospitals as a crucial part of patient care
• North America held the highest revenue share of over 38.09% of the market in 2024. In North America, there is a high rate of pet ownership, with many homes keeping companion animals like dogs, cats, and small mammals

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Veterinary Intravenous (IV) Solutions Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Prevalence of Animal Disease and Dehydration
    • 3.2.1.2. Rising Uptake of Pet Insurance
    • 3.2.1.3. Increase in Pet Ownership and Pet Expenditure
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Risk of Infection and Complications
    • 3.2.2.2. Preference of Oral Alternatives
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Veterinary Intravenous (IV) Solutions Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Pricing Analysis
  • 3.3.5. Manufacturing, Demand, and Supply Chain Analysis
  • 3.3.6. Estimated Animal Population by key countries, key species, 2024

Chapter 4. Veterinary Intravenous (IV) Solutions Market: Animal Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Veterinary Intravenous (IV) Solutions Market: Animal Type Movement Analysis
• 4.3. Veterinary Intravenous (IV) Solutions Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
• 4.4. Production Animals
  • 4.4.1. Production Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Companion Animals
  • 4.5.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Intravenous (IV) Solutions Market: By Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Veterinary Intravenous (IV) Solutions Market: By Product Movement Analysis
• 5.3. Veterinary Intravenous (IV) Solutions Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
  • 5.3.1. Isotonic crystalloids
    • 5.3.1.1. Isotonic crystalloids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Synthetic colloids
    • 5.3.2.1. Synthetic Colloids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Blood products
    • 5.3.3.1. Blood Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.4. Dextrose solution
    • 5.3.4.1. Dextrose Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.5. Parenteral nutrition
    • 5.3.5.1. Parenteral Nutrition Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Intravenous (IV) Solutions Market: By Indication Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Veterinary Intravenous (IV) Solutions Market: By Indication Movement Analysis
• 6.3. Veterinary Intravenous (IV) Solutions Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 6.3.1. Diabetic Ketoacidosis
    • 6.3.1.1. Diabetic Ketoacidosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Pancreatitis
    • 6.3.2.1. Pancreatitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Anthrax
    • 6.3.3.1. Anthrax Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. Chronic Kidney Disease
    • 6.3.4.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Others
    • 6.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Intravenous (IV) Solutions Market: By End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Veterinary Intravenous (IV) Solutions Market: By End Use Movement Analysis
• 7.3. Veterinary Intravenous (IV) Solutions Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.3.1. Veterinary Hospitals
    • 7.3.1.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. Research Institutes
    • 7.3.2.1. Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Others
    • 7.3.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Intravenous (IV) Solutions Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Veterinary Intravenous (IV) Solutions Market Share, By Region, 2024 & 2030 (USD Million)
• 8.3. Regional Outlook
• 8.4. North America
  • 8.4.1. North America Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. U.S. Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Canada Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Mexico Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. UK Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Germany Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. France Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Italy Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Spain Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Denmark Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Sweden Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Norway Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Japan Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. China Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. India Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Australia Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. South Korea Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Thailand Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Brazil Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Argentina Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. South Africa Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Saudi Arabia Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. UAE Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Kuwait Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Market Position Analysis/ Heap Map Analysis
• 9.3. Company Profiles
  • 9.3.1. Merck & Co., Inc
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Dechra.
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Animalcare Limited
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Elanco Animal Health Incorporated
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Zoetis
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Scopio B. Braun Vet Care (B Braun SE)
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
• 9.4. Strategy Mapping
  • 9.4.1. Mergers & Acquisitions
  • 9.4.2. Partnerships & Collaborations
  • 9.4.3. Product launch
  • 9.4.4. Others
• 9.5. List of other key players